noThumbs = true, sDelay = 7000

Stanford TAVR Program

Minimally-invasive, catheter-based therapy

Stanford TAVR Program
(650) 725-2621
Boswell Building
Room A260
300 Pasteur Drive
Stanford, CA 94305

Providing Needed Relief for Patients with Aortic Stenosis

Transcatheter aortic valve replacement (TAVR) is a less invasive procedure used to treat patients with severe aortic stenosis who are at increased risk for traditional surgical aortic valve replacement. Aortic stenosis causes a narrowing of the aortic valve which makes it more difficult for the heart to pump blood.


The TAVR procedure enables the delivery of an artificial heart valve, through a small incision, using a catheter-based approach. The new valve functions like a normal heart valve, improves blood flow, and reduces symptoms caused by aortic stenosis. Stanford is one of only three hospitals in Northern California that performs this procedure.

New Device, Hybrid Team Restore Ailing Heart Valves Once Inoperable

Stanford patient Gary Verwer was diagnosed with severe aortic stenosis, but due to a bypass surgery years earlier he was not eligible for open surgical valve replacement. Verwer instead underwent a new, less invasive procedure as part of a clinical trial, called transcatheter aortic valve replacement or TAVR.

Meet Our Team

TAVR in the News

FDA-approved transcatheter approach offers life-extending valve replacement for inoperable patients ABC-7 News Report: New Technology for Older Patients with Aortic Stenosis

About TAVR

TAVR Referring Physician Letter TAVR Fact Sheet

Stanford Medicine Resources:

Footer Links: